Navigation Links
Genopole(R) to Accompany 7 Companies and a Research lab to BIO Atlanta
Date:4/23/2009

EVRY, France, April 23 /PRNewswire/ -- The 2009 edition of the Biotechnology Industry Organization (BIO) Conference and Exhibition will take place in Atlanta from May 18th-20th. Genopole(R) will participate in this major event as part of a delegation from the Paris Ile-de-France Region. Seven of Genopole(R)'s innovative companies (BioQuanta, Drugabilis, GenOptics, Innavirvax, Texcell, Watchfrog and Xentech) and the I-Stem research lab will, attend.

The annual BIO show attracts most of the global stakeholders in the biotech sector and is an event that a biopark like Genopole(R) cannot afford to miss! Since Genopole(R)'s creation in 1998, the cluster has been a regular attendee at an event that delivers true international visibility.

The Paris Ile-de-France region's key biotech players will be well represented at BIO 2009. Alongside the Paris Region Economic Development Agency (ARD), the Genopole(R) Biopark and the Medicen Bio Region will each accompany 7 companies. The Biocitech, Paris Biopark and Cancer Campus bioparks have also joined the delegation.

Genopole(R) members BioQuanta, Drugabilis, GenOptics, Innavirvax, Texcell, Watchfrog and Xentech will be attending BIO this year. "The event is a great opportunity for our companies to present their products, expertise and know-how. The business conventions, seminar sessions and forums are all vectors for meeting future partners and clients", explained Eric Lameignere (Director, Genopole(R) Entreprises).

Resource sharing is a key development theme for bioparks. Naceur Tounekti (Director, Genopole Infrastructure) will give a talk on this subject during the session entitled "Bio-Manufacturing and High-Tech Facilities: How to Share Tools Between Bio-Regions?" (Tuesday May 19th, from 4:00 pm to 5:30 pm- Room B312-Building B).

As a prelude to BIO, the third edition of the "Fast-Track R&D Partnering with France" event will take place on Monday May 18th, from 2:00 pm onwards. The seminar will give over 100 company managers, researchers and academics from across the world an opportunity to identify and initiate R&D collaborations with French partners. This interfacing event is been organized by France's 8 healthcare/biotech clusters (including Medicen from the Paris Region) and is led by Lyonbiopole, in collaboration with the UbiFrance international trade agency and with funding from the French Ministry of Industry.

http://www.fasttrackbio.com/2009

http://www.genopole.fr


'/>"/>
SOURCE Genopole
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego
2. The Pittsburgh Life Sciences Greenhouse Adds New Companies to its Investment Portfolio
3. New White Paper Details Strategies for Biotechnology Companies to Improve EH&S Compliance
4. Beaumont Technology Usability Center To Offer Training For Medical Technology Companies
5. Deloitte Leadership Offers Crucial Convergence Considerations for Life Sciences Companies
6. Michigan Life Science Network to Form Two New Virtual Companies
7. Michigan Life Science Network: Virtual Companies Get Global Reception
8. 2007 Massachusetts Biotechnology Council MASS Opportunities Investment Conference Showcases Leading Growth Companies
9. Virtual Life Science Companies Launch and Tour
10. Align Technology, Inc. Ranked 23rd in Deloittes Technology Fast 50 Program for Silicon Valley Scientific & Medical Equipment, and Bio-Technology Companies
11. Medical Services Begins Working With United States Companies for Distribution of Its Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... 2017 , ... Disappearing forests and increased emissions are the main causes of ... year. Especially those living in larger cities are affected by air pollution related diseases. ... most pollution-affected countries globally - decided to take action. , “I knew I had ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator ... osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular STAT3 ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it ... Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and CEO of ... Club. The event entitled “Stem Cells and Their Regenerative Powers,” was ... Dr. Harman, DVM, MPVM was joined by two human doctors: Peter B. Hanson, M.D., ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... to expand at a CAGR of 25.76% during the ... is the primary factor for the growth of the ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem ... technology, application, and geography. The stem cell market of ...
(Date:3/30/2017)... March 30, 2017 Trends, opportunities and forecast ... behavioral), by technology (fingerprint, AFIS, iris recognition, facial recognition, ... others), by end use industry (government and law enforcement, ... and banking, and others), and by region ( ... Asia Pacific , and the Rest ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Industry Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access ... 15.1% over the next decade to reach approximately $1,580 million by ... and forecasts for all the given segments on global as well ...
Breaking Biology News(10 mins):